LARS1 and central nervous system cancer: Moreover, we identified that several underexplored LARs, such as ESC O 2, HAT1(KAT1), and LEF1, may have prognostic value in lower grade glioma patients (Supplementary Table S5) and may be potential glioma biomarkers.